Abstract
To the Editor: We read with considerable interest the article by de la Sierra et al1 clarifying the prevalence and clinical features of resistant hypertension based on office and ambulatory blood pressure (BP) monitoring in a large cohort of treated hypertensive patients in Spain. The prevalence of white-coat resistant hypertension (24-hour ambulatory BP <130/80 mm Hg for systolic/diastolic) and true resistant hypertension (24-hour ambulatory BP ≥130 and/or 80 mm Hg) was 37.5% and 62.5% among patients with uncontrolled office BP (≥140 and/or 90 mm Hg) and taking ≥3 antihypertensive drugs. They also demonstrated a difference in characteristics between white-coat and true resistant hypertension. These findings indicate that physicians …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
